Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
ESMO Open|August 15, 2022
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)I Hartlapp, D Valta-Seufzer, J T Siveke, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2015
PanGen-Fam: Spanish registry of hereditary pancreatic cancerE Mocci, C Guillen-Ponce, J Earl, et al.
ESMO Open|July 17, 2024
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivityI-A Mavroeidi, J Burghofer, S Kalbourtzis, et al.
ESMO Open|January 9, 2024
Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter studyJ Keyl, A Bucher, F Jungmann, et al.
ESMO Open|February 5, 2022
Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 studyS F Kruger, A Lohneis, A Abendroth, et al.
International Journal of Epidemiology|January 13, 2018
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relativesE Molina-Montes, P Gomez-Rubio, M Márquez, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 21, 2021
Gallbladder disease and pancreatic cancer risk: a multicentric case-control European studyV Rosato, P Gómez-Rubio, E Molina-Montes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer riskP Gomez-Rubio, V Rosato, M Márquez, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?D William, M Bermúdez, A Kübler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2022
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancersA Jahn, A Rump, T J Widmann, et al.
Pageof 13